Literature DB >> 2654190

Peripheral T cell lymphoma: value of bone marrow trephine immunophenotyping.

D M White1, A G Smith, J M Whitehouse, J L Smith.   

Abstract

Bone marrow infiltrates taken from 11 patients with peripheral T cell lymphoma were immunophenotyped as T cell lymphoma using monoclonal antibodies on frozen bone marrow trephine biopsy specimens. In nine these were taken at diagnosis and in two after failure of treatment to eradicate lymphoma in the marrow. Patterns of infiltration were as follows: diffuse (n = 4), interstitial (n = 1), nodular (n = 1), focal (n = 5). All cases were CD3 positive and 10 were CD2 positive; five lacked expression of either CD5 or CD7, or both markers. In nine the determination of T cell phenotype depended on analysis of the frozen bone marrow trephine biopsy specimen as there was no other biopsy tissue available for study. In the other two cases there was agreement between the immunophenotypes seen in lymph node and bone marrow infiltrates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2654190      PMCID: PMC1141913          DOI: 10.1136/jcp.42.4.403

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  25 in total

1.  Limitations encountered in the application of tissue section immunodiagnosis to the study of lymphomas and related disorders.

Authors:  R A Warnke; R V Rouse
Journal:  Hum Pathol       Date:  1985-04       Impact factor: 3.466

2.  Peripheral T-cell lymphoma: aggressive disease with heterogeneous immunotypes.

Authors:  T M Grogan; K Fielder; C Rangel; C J Jolley; D P Wirt; M J Hicks; T P Miller; R Brooks; B Greenberg; S Jones
Journal:  Am J Clin Pathol       Date:  1985-03       Impact factor: 2.493

3.  Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas.

Authors:  L M Weiss; G S Crabtree; R V Rouse; R A Warnke
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

4.  Membrane phenotype and response to deoxycoformycin in mature T cell malignancies.

Authors:  C E Dearden; E Matutes; A V Hoffbrand; K Ganeshaguru; M Brozovic; H J Williams; N Traub; M Mills; D C Linch; D Catovsky
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-10

5.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

6.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

7.  Immunohistological analysis of human bone marrow trephine biopsies using monoclonal antibodies.

Authors:  B Falini; M F Martelli; F Tarallo; D J Moir; J L Cordell; K C Gatter; G Loreti; H Stein; D Y Mason
Journal:  Br J Haematol       Date:  1984-03       Impact factor: 6.998

8.  Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67.

Authors:  J Gerdes; F Dallenbach; K Lennert; H Lemke; H Stein
Journal:  Hematol Oncol       Date:  1984 Oct-Dec       Impact factor: 5.271

9.  Bone marrow and blood involvement by lymphoma in relationship to the Lukes--Collins classification.

Authors:  K Foucar; R W McKenna; G Frizzera; R D Brunning
Journal:  Cancer       Date:  1982-03-01       Impact factor: 6.860

10.  Routine immunofluorescent and histochemical analysis of bone marrow involvement of lymphoma/leukaemia: the use of cryostat sections.

Authors:  M Chilosi; G Pizzolo; L Fiore-Donati; M Bofill; G Janossy
Journal:  Br J Cancer       Date:  1983-12       Impact factor: 7.640

View more
  1 in total

1.  Assessment of proliferative activity in leukaemic bone marrow using the monoclonal antibody Ki-67.

Authors:  D M White; A G Smith; J L Smith
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.